Quantcast

Industry news that matters to you.  Learn more

NIH Launches Collaborative Effort to find Biomarkers for Parkinson’s

A new initiative aims to accelerate the search for biomarkers — changes in the body that can be used to predict, diagnose or monitor a disease — in Parkinson’s disease, in part by improving collaboration among researchers and helping patients get involved in clinical studies.

Lundbeck Canada Donates $2.7 Million to Fund Ground-breaking Depression Research

Lundbeck Canada has made a landmark donation of $2.7 million to support ground-breaking research at the University Health Network to identify biomarkers (biological markers) that will enhance the diagnosis and treatment of patients suffering from major depression and bipolar disorder.

Orasi Medical Partners with Biogen Idec to Use Its Novel Biomarker Technology

Orasi Medical announced today that the company has entered into an agreement with Biogen Idec to test novel biomarkers in the development of treatments for central nervous system (CNS) disorders. Under the agreement, the companies will utilize the Orasi Medical technology to identify and test biomarkers based on magnetoencephalography (MEG). Non-invasive and patient friendly MEG scans will be used to assess the integrity of brain communication networks in real time and measure brain function in patients.

Tau Linked to a Specific Brain Area and Function in Alzheimer’s Disease

Earlier this week, University of Minnesota researchers said that they have established a firm relationship between the Tau protein and Alzheimer’s disease. Tau has long been considered a biomarker for onset of Alzheimer’s disease.

Mayo Clinic Finds Seizure Generation in Brain is Isolated from Surrounding Brain Regions

Mayo Clinic researchers found that the part of the brain generating seizures in individuals with epilepsy is functionally isolated from surrounding brain regions. The researchers hope this finding could be a clinical biomarker to help identify individuals with abnormal brain function. This study was presented at the American Epilepsy Society’s annual meeting in San Antonio on Dec. 4.